Estrella Immunopharma, Inc. (ESLA): debt financing — TradeUP Acquisition Corp. issues $50,000 promissory note to founder for working capital

Estrella Immunopharma, Inc.

$50,000 unsecured promissory note issued to Tradeup INC., a founder of the SPAC.
Note bears no interest; payable upon business combination or expiry of SPAC term.
Payee may convert note into shares at $10.00 per share prior to business combination.
Proceeds used for general working capital purposes.
Issuance exempt from registration under Section 4(a)(2) of Securities Act.

item 1.01 item 2.03 item 3.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Estrella Immunopharma, Inc. incurred loan of $50,000 with Tradeup INC. at no interest.

Instrument: loan
Principal: $50,000
Counterparty: Tradeup INC.
Rate: no interest
Event: incurrence

Exact text from the filing

On March 3, 2023, TradeUP Acquisition Corp. (the “Company”) issued an unsecured promissory note (the “Promissory Note”) in the amount of $50,000 to Tradeup INC., one of the founders of the Company.

View on SEC.gov

Browse all debt financings →

Estrella Immunopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001575872-23-000316

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.